[The treatment of chronic viral hepatitis B/D and acute and chronic viral hepatitis C. The consensus of the German Society for Digestive and Metabolic Diseases].
Hopf
U
U
Klinik und Poliklinik für Innere Medizin 1, Klinikum Kröllwitz, Martin-Luther-Universität Halle-Wittenberg.
Niederau
C
C
Kleber
G
G
Fleig
W E
WE
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000628:therapy; D000208:Acute Disease; D000998:Antiviral Agents / Q000627:therapeutic use; D002908:Chronic Disease; D000075202:Contraindications; D005762:Gastroenterology; D005858:Germany; D015497:HIV-1; D006509:Hepatitis B / Q000175:diagnosis / Q000628:therapy*; D006526:Hepatitis C / Q000175:diagnosis / Q000628:therapy*; D019698:Hepatitis C, Chronic / Q000175:diagnosis / Q000628:therapy*; D003699:Hepatitis D / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects / Q000627:therapeutic use; D011379:Prognosis; D012955:Societies, Medical
D000998:Antiviral Agents; D016898:Interferon-alpha
Behandlung der chronischen Virushepatitis B/D und der akuten und chronischen Virushepatitis C. Konsensus der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten.